Loading clinical trials...
Loading clinical trials...
Acute Myeloid Leukemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible for fighting infections). This study will assess how safe and effective oral venetoclax i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07500441 · Acute Myeloid Leukemia (AML)
NCT05768932 · Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer, and more
NCT05756777 · Acute Myeloid Leukemia (AML)
NCT04990102 · Acute Myeloid Leukemia (AML) in Remission
NCT07451912 · Acute Myeloid Leukemia (AML), CEBPA Mutation, and more
Pusan National University Hospital /ID# 239010
Busan, Busan Gwang Yeogsi
Kosin University Gospel Hospital /ID# 257399
Busan, Busan Gwang Yeogsi
Kyungpook National University Hospital /ID# 257398
Daegu, Daegu Gwang Yeogsi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions